Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: N06AX26

Brintellix(vortioxetine)

Depressive Disorder, Major

Marketing Authorisation Holder: H. Lundbeck A/S

EMA Authorisation: 18/12/2013

INN: vortioxetine

Indication

Treatment of major depressive episodes in adults.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Brintellix — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.